Induction Chemotherapy with FTD/TPI and Oxaliplatin in Resectable EGAC: Preliminary Phase II Study Results Gastrointestinal 3 Mins Read19 Sarbajit Mukherjee, MD, MS, Assistant Professor, Roswell Park Comprehensive Cancer Center conducted a study to investigate the efficacy of a…
FRESCO-2 Trial Meets Endpoints: Metastatic Colorectal Cancer Colorectal 15 Mins Read4 FRESCO-2 Trial Met Primary Endpoints in Patients With Metastatic Colorectal announced HUTCHMED from the Fruquintinib Global Phase III Trial The…
